← Back to Search

At-Home Supportive Cancer Care for Advanced Cancer

N/A

Waitlist Available

Led By Ryan D Nipp, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with advanced cancer (defined as receiving treatment with palliative intent per chemotherapy order entry treatment intent designation and/or trial consent forms OR based on documentation in the oncology clinic notes for those not receiving chemotherapy)

Admitted with an unplanned or non-elective hospitalization at Massachusetts General Hospital (MGH)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is testing if this program can help recently hospitalized patients with advanced cancer by providing better post-discharge care.

Who is the study for?

This trial is for English-speaking adults over 18 with advanced cancer, recently hospitalized at MGH without ICU care. They must live within 50 miles of MGH and be discharged home, not to hospice or other locations. Caregivers and clinicians involved in their care are also eligible if they meet similar criteria.Check my eligibility

What is being tested?

The study tests a home-based supportive oncology care program post-discharge involving remote monitoring (symptoms, vitals), Medically Home model for symptom management, and structured communication with the oncology team.See study design

What are the potential side effects?

Since this intervention involves non-medical adjustments to patient monitoring and support rather than pharmaceuticals or invasive procedures, typical medical side effects are not expected; however, there may be logistical or technical issues that could affect patient experience.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am diagnosed with advanced cancer and am receiving treatment to ease symptoms.

Select...

I was unexpectedly admitted to Massachusetts General Hospital.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rates of completion of daily symptom assessment

Rates of study enrollment

Secondary outcome measures

Change in care satisfaction score longitudinally throughout the study

Change in caregivers reports of patients' symptom burden longitudinally throughout the study

Change in psychological distress score longitudinally throughout the study

+24 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Oncology Care at HomeExperimental Treatment1 Intervention

Participants will receive the Supportive Oncology Care at Home program for 14 days following their discharge from the hospital. The Supportive Oncology Care at Home intervention consists of three key components: Daily monitoring of patient-reported symptoms, vital signs, and body weight. Medically Home care based on algorithmic changes in patients' daily symptoms, vital signs, and body weight. Structured communication with the oncology team regarding care delivered to ensure continuity of care.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Medically Home Group, Inc.UNKNOWN

Massachusetts General HospitalLead Sponsor

2,925 Previous Clinical Trials

13,197,779 Total Patients Enrolled

Ryan D Nipp, MDPrincipal InvestigatorMassachusetts General Hospital

Media Library

Cancer Research Study Groups: Supportive Oncology Care at Home

Cancer Clinical Trial 2023: Supportive Oncology Care at Home Highlights & Side Effects. Trial Name: NCT04637035 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in this clinical trial for new patients?

"According to clinicaltrials.gov, this particular trial is not recruiting new patients at the moment. The listing was originally posted on August 19th 2021 but was last updated on August 22nd 2022. Even though this study isn't looking for any more participants, there are 501 other trials that are still enrolling individuals."

Answered by AI

What are the primary goals of this clinical trial?

"The primary outcome metric of this trial, which will span a period of 2 years, is enrollment rates. Additionally, the researchers will also track emergency department visits, phone call durations, and urgent clinic visits as secondary outcomes."

Answered by AI

Recent research and studies

BMC CancerJournal

Supportive Oncology Care at Home Interventions: Protocols for Clinical Trials to Shift the Paradigm of Care for Patients with Cancer

Nipp, Ryan D., Eliza Shulman, Melissa Smith, Patricia M. C. Brown, P. Connor Johnson, Eva Gaufberg, Charu Vyas, et al.. 2022. “Supportive Oncology Care at Home Interventions: Protocols for Clinical Trials to Shift the Paradigm of Care for Patients with Cancer”. BMC Cancer. Springer Science and Business Media LLC. doi:10.1186/s12885-022-09461-z.

clinicaltrials.govStudy

Supportive Oncology Care at Home Post-Discharge

Ryan Nipp 2021. "Supportive Oncology Care at Home Post-Discharge". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04637035.